X
Dow Jones

The Dow Jones Rallies After Gilead Drug Shows Promise in Treating COVID-19

By , Executive Producer, Money Morning

Garrett Baldwin

The Dow Jones popped this morning on news that a drug from Gilead Sciences Inc. (NASDAQ: GILD) showed some effectiveness in treating patients with the coronavirus.

Shares of the drug company surged 16% after the bell on a report from a Chicago hospital that showed progress from Remdesivir. More on this below.

First, here are the numbers from Thursday for the Dow, S&P 500, and Nasdaq:

Index Previous Close Point Change Percentage Change
Dow Jones 23,537.68 +33.33 +0.14
S&P 500 2,799.55 +16.19 +0.58
Nasdaq 8,532.36 +139.19 +1.66

Now let's take a look at what I consider to be the most important market events to start your day.

The Top Stock Market Stories for Friday

The Best Stocks to Buy Now: 2020's market free fall has been gut-wrenching, but there's a silver lining: It's opening up a chance to get into great stocks at low prices we might never see again in our lifetime. Click here...

Stocks to Watch Today: BA, GE, F, GM, PG

The New Rules for Buying Low and Selling High in Today's Market

If you want to buy low and sell high in today's market, there's only one rule you need to follow.

Today, Tom Gentile is sharing everything - including the exact formula that could magnify your profits faster than you could ever believe.

Take a look.

Follow Money Morning onFacebook and Twitter.

About the Author

Garrett Baldwin is a globally recognized research economist, financial writer, consultant, and political risk analyst with decades of trading experience and degrees in economics, cybersecurity, and business from Johns Hopkins, Purdue, Indiana University, and Northwestern.

Read full bio